STK11 alterations as predictive biomarkers of resistance to immune checkpoint inhibitors in multiple cancers with mismatch repair gene alterations

被引：0
|
作者：
Iglesia, Michael
Khushman, Moh'd M.
Lim, Kian-Huat
Van Tine, Brian Andrew
Liu, Jingxia
Pedersen, Katrina Sophia
Liu, Xiuli
Trikalinos, Nikolaos
Suresh, Rama
Aranha, Olivia
Grierson, Patrick
Tan, Benjamin R.
Govindan, Ramaswamy
机构：
[1] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA
[2] Washington Univ St Louis, Siteman Canc Ctr, St Louis, MO USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Washington Univ St Louis, St Louis, MO USA
[5] Washington Univ, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2619
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The differential response to immune checkpoint inhibitors in colorectal and endometrial cancer patients according to different mismatch repair alterations.
    Khushman, Moh'd M.
    Toboni, Michael Driscoll
    Zeng, Jia
    Xiu, Joanne
    Manne, Upender
    Farrell, Alex
    El-Rayes, Bassel F.
    Lou, Emil
    Shields, Anthony Frank
    Philip, Philip Agop
    Salem, Mohamed E.
    Abraham, Jim
    Spetzler, David
    Marshall, John
    Jayachandran, Priya
    Hall, Michael J.
    Lenz, Heinz-Josef
    Korn, Wolfgang Michael
    Powell, Matthew A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [12] Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
    Elbehi, Attia M.
    Anu, R., I
    Ekine-Afolabi, Bene
    Cash, Elizabeth
    ORAL ONCOLOGY, 2020, 109
  • [13] Efficacy of immune checkpoint inhibitors for gastrointestinal cancers with SWI/SNF complex genetic alterations
    Nakata, Akinobu
    Narita, Yukiya
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Kodama, Hiroyuki
    Honda, Kazunori
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Andoh, Masashi
    Yamaguchi, Rui
    Tajika, Masahiro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [14] Efficacy of immune checkpoint inhibitors for gastrointestinal cancers with SWI/SNF complex genetic alterations
    Nakata, Akinobu
    Narita, Yukiya
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Kodama, Hiroyuki
    Honda, Kazunori
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Ando, Masashi
    Yamaguchi, Rui
    Tajika, Masahiro
    Muro, Kei
    ANNALS OF ONCOLOGY, 2022, 33 : S493 - S493
  • [15] Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) - analysis of somatic alterations (SAs)
    Singavi, A. K.
    Menon, S.
    Kilari, D.
    Alqwasmi, A.
    Ritch, P. S.
    Thomas, J. P.
    Martin, A. L.
    Oxencis, C.
    Ali, S.
    George, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [16] DNA mismatch repair deficient cancer - Emerging biomarkers of resistance to immune checkpoint inhibition
    Brooksbank, Kirsten
    Martin, Sarah A.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 164
  • [17] Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
    Noh, Joseph J.
    Kim, Min Kyu
    Choi, Min Chul
    Lee, Jeong-Won
    Park, Hyun
    Jung, Sang Geun
    Joo, Won Duk
    Song, Seung Hun
    Lee, Chan
    CANCER RESEARCH AND TREATMENT, 2022, 54 (04): : 1200 - 1208
  • [18] Predictive biomarkers and protein specific mismatch repair (MMR) loss in gastrointestinal (GI) tumours on immune checkpoint inhibitors (ICI): Correlation with survival
    Le, H. M. L.
    Paiva, R. V. D. S.
    Farag, S.
    Dadouli, K.
    Ntellas, P.
    Cunningham, D.
    Starling, N.
    Rao, S.
    Fribbens, C.
    Chau, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S204 - S204
  • [19] EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
    Zhang, Zhen
    Wu, Hao-Xiang
    Lin, Wu-Hao
    Wang, Zi-Xian
    Yang, Lu-Ping
    Zeng, Zhao-Lei
    Luo, Hui-Yan
    BMC MEDICINE, 2021, 19 (01)
  • [20] EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
    Zhen Zhang
    Hao-Xiang Wu
    Wu-Hao Lin
    Zi-Xian Wang
    Lu-Ping Yang
    Zhao-Lei Zeng
    Hui-Yan Luo
    BMC Medicine, 19
12345